Skip to main content
. Author manuscript; available in PMC: 2020 Feb 4.
Published in final edited form as: Thromb Haemost. 2018 Oct 9;118(11):1969–1981. doi: 10.1055/s-0038-1673342

Table 1.

Circulating and MPC-associated monocytes in blood of healthy individuals and patients with AMI.

Total monocytes Classical
monocytes		 Intermediate
monocytes		 Non-classical
monocytes
Healthy patients
Circulating monocytes 478.12±52.14 437.62±34.79
(90.34±0.56%)		 30.59±3.89
(6.14 ±0.52%)		 15.12±2.08
(3.01±0.29%)
MPC 20.62±1.86
(4.35±0.23%)		 14.48±1.60
(3.23±0.16%)		 3.06±0.68
(10.29±1.37%)		 0.44±0.27
(3.23±0.32%)
AMI patients
Circulating monocytes 630.65 ± 49.83 580.24 ±33.17
(90.44 ±0.89%)		 41.24± 4,85
(6.50 ±0.65%)		 15.28±2.06
(2.59±0.36%)
MPC 63.89±7.74
(11.13±1.61%)		 40.74±5.47
(7.90±1.32%)		 7.31± 1.50
(18.41 ±1.99%)		 1.09±0.26
(6.76±0.84%)

Data are presented as mean concentrations (counts/μL) ± SEM of monocytes circulated as single cells or as a part of MPC. For monocytes, data in parentheses denote percentages of circulating monocyte subsets among the total monocytes in peripheral blood. For MPC, data in parentheses denote the percentage of monocytes among total monocytes or individual monocyte subsets.